Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Co-agonists of the glucagon and GLP-1 receptors

Co-agonists of the glucagon and GLP-1 receptors

US Patent 10493125 · Granted Dec 3, 2019

Estimated economic value: $327,670,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Small molecule inhibitors of KRAS G12C mutant2025
Small molecule inhibitors of KRAS G12C mutant2025
Epstein-Barr Virus antigen constructs2025
Arginase inhibitors and methods of use2025
Arginase inhibitors and methods of use2025
PCSK9 antagonist compounds2025
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammator2024
Cyclic polypeptides for PCSK9 inhibition2024
Cyclic polypeptides for PCSK9 inhibition2024
Compositition and uses of teleost invariant chain to enhance T cell response to 2024
Epstein-barr virus antigen constructs2023
Antibody peptide conjugates that have agonist activity at both the glucagon and 2023